FDA Inspection 1230661 — Idliko Csurke, M.D.
The FDA completed an inspection of Idliko Csurke, M.D. on Dec 12, 2023 in Nyiregyhaza. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Nyiregyhaza (Hungary)
Additional Details
Clinical Investigator (CI)